CU-IBC Institutional Biosafety Committee formerly the Recombinant DNA Committee Frank Cantone, Interim IBC Chair Cornell University Biological Safety Officer.

Slides:



Advertisements
Similar presentations
THE NIH RECOMBINANT DNA 2002 GUIDELINES East Carolina University September 5, 2007.
Advertisements

Research Study Initiation Process GRU CLINICAL AND TRANSLATIONAL RESEARCH LABORATORY RESEARCH ANIMAL RESEARCH HUMAN RESEARCH GRU Clinical.
An Overview of Sponsored Programs at Dennis Manos Vice Provost for Research.
TEXAS SOUTHERN UNIVERSITY OFFICE OF RESEARCH LINDA M. GARDINER, Ph.D. DIRECTOR DEPARTMENT OF RESEARCH ENHANCEMENT AND COMPLIANCE SERVICES.
TEXAS SOUTHERN UNIVERSITY INSTITUTIONAL ANIMAL CARE AND USE PROGRAM WORKSHOP OFFICE OF RESEARCH LINDA M. GARDINER, Ph.D. DIRECTOR RESEARCH ENHANCEMENT.
Outline Introduction to the National Institutes of Health Office of Biotechnology Activities History and Evolution of IBCs: Asilomar to the Present Overview.
Responsible Conduct of Research & Research Compliance Adam J. Rubenstein, Ph.D. Director of Research Compliance Old Dominion University Office of Research.
Biological and Radiological Regulatory Concerns for Research Administrators Megan G. Marks, Ph.D. Biological and Radiological Safety Manager Carnegie Mellon.
Biosafety Program Development Presented by: Lisa Wisser, CIH AIHCE - June 6, 2001.
Public and Private Interests in Animal Research LAT Chapter 1.
Office of the Vice President for Research
Principles and Practices of Biosafety Environmental Health and Safety San Diego State University.
Presented by the Office of Contracts and Grants University of San Francisco November 2011.
Disclosure of Conflicts of Interest and Commitment Why do we collect COI disclosures, and from whom do we collect? A note about our system of collection,
Disclosure of Conflicts of Interest and Commitment Why do we collect COI disclosures, and from whom do we collect? A note about our system of collection,
Coming Soon... Mandatory Biosafety Training David W. Emery, Ph.D. Research Associate Professor of Medicine & Chair, Institutional Biosafety Committee On.
WSU Biosafety Officer Lorraine McConnell
Institutional Biosafety Committee and Biological Use Authorization.
ERIKA BARRETT TECHNICIAN, BIOLOGICAL SAFETY OFFICE OF RADIATION, CHEMICAL & BIOLOGICAL SAFETY FRIDAY, OCTOBER 3.
Office of Research Integrity Office of Research Integrity Orientation Session November 8, 2012 ECSS
Research and Biological Safety Office Environmental Health and Safety
Safety Review and Approval Process for Research Proposals Robert Emery, DrPH, CHP, CIH, CBSP, CSP, CHMM, CPP, ARM Vice President for Safety, Health, Environment.
Use and Care of Vertebrate Animals: What Researchers Need to Know Brian Greene IACUC Chair and Associate Professor of Biology Missouri State University.
The University of California Sponsored Project Funding: Pre-Award Nancy R. Lewis Director, Sponsored Projects Administration University of California,
LABORATORY BIOSAFETY FOCUS FORUM (LBFF). Delia Wolf Office of Regulatory Affairs & Research Compliance Dana Burns Leslie Howes Stanley Estime Jennifer.
The proper protocol for grant approval at LCSC GRANT-WRITING 101: INTERNAL PROCEDURES.
IACUC and IBC PROCESS. Office of Research Services Resource Center Building Room Kenneth Kratz, PhD –Director Staff: Nicole Barron – Pre-award.
R ESEARCH P ROTECTIONS R EVIEW & F UNDING Nancy Stalnaker, Director & Donna Silver, Assistant Director UVM Research Protections Office 6/3/2013UVM Research.
INSTITUTIONAL REVIEW OF BIOSAFETY RESEARCH Review of Institutional Biosafety Committee Application Form Robert J. Hashimoto The University of Kentucky.
IACUC Institutional Animal Care and Use Committee.
Office of the Vice Chancellor for Research 1 Update on PHS New Rule on Financial Conflicts of Interest (FCOI) Presentation to Business Managers January.
1 KRA Research Compliance Kuali Days VI Presenters: Lori Schultz, University of Arizona E. Ray Stinson, Ph.D., Cornell University May 14, 2008.
Nov 2, 2010 Yonette F. Thomas, Ph.D. Associate Vice President for Research Compliance Howard University Research Compliance Office Responsible Conduct.
Safety organization and training. The biosafety officer and biosafety committee A safety policy, A safety manual, and Supporting programmes for their.
Office of Research Integrity and Assurance To ensure university compliance with local, state, and federal regulations through ethical and responsible conduct.
IACUC Procedures James Weiland, PhD Professor of Ophthalmology/BME IACUC Chair
Research Compliance: An Overview of the Players and Issues Involved in Emory’s Research Compliance Programs.
Animal Research at Princeton Prepared by Stuart Leland Director, Research Integrity and Assurance For use and distribution by the Princeton University.
Fundamentals for Faculty Andrea Deaton, CRA Executive Director Office of Research Services
3/18/14 SERIES 4, SESSION 3 OF AAPLS – TITLE APPLICANTS & ADMINISTRATORS PREAWARD LUNCHEON SERIES Limited Submissions.
Rebecca Nickleson, MS, CRA Assistant Director Office of Research & Sponsored Programs.
Office of Sponsored Projects The Funding Life Cycle.
Research Protections Office University of Vermont Change to Procedures for Committee Review of Resubmissions of Grant Applications.
LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER NEW ORLEANS.
Limited Submissions NCURA Region III Spring Meeting.
 Welcome ◦ Amanda Athey, Director, Graduate School  Student Experience  Funding Opportunities ◦ Rebecca Drake, Research Administrator, Office of Research.
R EGULATORY A GENCIES What are regulatory issues? Types of agencies How they affect you Top 10 regulatory issues.
Office of Sponsored Projects The Funding Life Cycle.
The Ins and Outs of PI Transfers A departmental administration perspective on faculty moves between institutions Jennifer Cory & Tim Reuter.
Research as defined by DHHS A systematic investigation, including research development, testing and evaluation, designed to develop or contribute to generalizable.
NIH Guidelines for Research Involving rDNA Molecules (NIH Guidelines) and Institutional Biosafety Committees.
Survey of Institutional Biosafety Committees Raymond W. Hackney, DrPH, CIH, CBSP University of North Carolina at Chapel Hill “The Future Face of Institutional.
The IBC is: The Institutional Biosafety Committee (aka Biohazards Committee)
Welcome to the Butler Institute for Research & Scholarship (BIRS) Presented by Taura Edwards, BIRS Director Kanti Crain, Research Compliance Officer.
Biosafety at Swinburne
Overview of the NIH Guidelines for Research Involving Recombinant DNA Molecules This is an edited combination of Haverford College’s IBC training materials.
Introduction Review and proper registration of Human Gene Transfer protocols is very complex. A protocol goes through rigorous review by multiple Committees.
Institutional Biosafety Committee (IBC)
ROLE OF THE INSTITUTIONAL BIOSAFETY COMMITTEE
Training Requirements for PI and Research Staff
Institutional Biosafety Committee (IBC)
Renewal Animal Training
Institutional Biosafety Committees
IBC REGISTRATION - Overview
Institutional Biosafety Committee (IBC)
Institutional Biosafety Committees
Institutional Biosafety Committee (IBC)
Institutional Biosafety Committee (IBC)
Institutional Biosafety Committee (IBC) OVERVIEW
Kathryn Harris, PhD, RBP Senior Outreach and Education Specialist
Presentation transcript:

CU-IBC Institutional Biosafety Committee formerly the Recombinant DNA Committee Frank Cantone, Interim IBC Chair Cornell University Biological Safety Officer Maria Golonski, Executive Secretary

What does the IBC do? Review all University research and teaching activities involving the use of REGULATED biological agents, toxins, and recombinant DNA molecules. Ensure that personnel and facilities are in compliance with all external regulations and applicable University policies. Recommend policies to guide principal investigators and EH&S in carrying out the University's Biosafety Program, i.e., acquisition, use, training, transfer, storage, disposal, and emergency response procedures for all biohazardous materials emphasizing the protection of personnel, the general public, and the environment. Safety - Containment - Training

NIH Guidelines for Membership Standing Committee of the Faculty Senate Vice Provost for Research –> SPS & EH&S Is now affiliated with ORIA (Office of Research Integrity & Assurance) – Compliance Office CU Faculty and Staff with various expertise from different fields At least two members shall not be affiliated with the university Who is the IBC?

IBC Members Jean Bonasera – Plant Pathology Frank Cantone (Interim Chair)– EH&S Alice Churchill – Plant Pathology Walter DeJong – Plant Genetics Ed Dubovi – Vet. Diagnostic Lab. Hazel Fromm – Community Member Susheng Gan – Horticulture Paul Jennette – Biosafety Engineer Pat McDonough – Pop Med & Diag Christy Michaels – Community Member Keith Perry – Plant Pathology Mark Roberson – Biomedical Science Jean Siracusa – Community Member Chris Smart – Plant Pathology Geneva Martin Wiedmann – Food Science Charlie Fay – VP Res. Admin. Charles Walcott – Assoc. Dean Faculty Steve Hughes - Gannett Clinic Bob Richardson - Vice Provost Res. Maria Golonski – Executive Secretary

 Recombinant DNA – NIH CU regulates all rDNA projects, incl. NIH-exempt projects  Infectious Pathogens – CDC, USDA, NIH, ABSA Human, Animal, Plant  Biological Toxins - CDC All research projects involving regulated biohazardous materials must be registered with the CU-IBC via a MUA ( Memorandum of Understanding and Agreement)

Step 1: SPS Receives Form 10 If rDNA, GMO or Biological Agent, boxes are checked - it triggers an SPS (IBC) response. PI receives an indicating that an MUA is required prior to the release of funds. Some agencies require approval when grant is submitted.

Step 2 Determine need for a MUA New or Revised PI will be informed of status of MUA and will be directed to submit a new protocol or an ammendment Information, Instructions, and Forms are on the website This should be consulted prior to submitting a Form 10 and any MUA forms.

Step 3: PI Completes Forms Proper forms must be completed in full Electronic submission is here!! Questions regarding the forms can be directed to Maria Golonski (mg352) at or Frank Cantone (fac2) at

Step 4: Committee Review Committee Chair and Biological Safety Officer review all MUAs Exempt projects are approved by the chair Non-exempt projects are assigned to a 3 person subcommittee for review Subcommittee reports on review and recommends project for approval Provisional approval may be granted at that time Funding cannot be released prior to this

Step 5: IBC Meetings The IBC meets the third Thursday of even months All meetings are open to the public – announced in the Ithaca Journal and Cornell Daily Sun At the meetings, all non-exempt proposals with completed subcommittee reviews are discussed and voted upon

MUA Lifetime All MUAs are good for 3 years from the date it was approved, HOWEVER….. Each year an annual questionnaire is required. A full review by the IBC is required every third year on all proposals

Compliance Issues Reminders to submit the Annual Updates is ed to PI at: 2 months prior to due date – 1 month prior to due date - 2 week prior to due date 1 week prior to due date -Every 7 days thereafter cc Dept Chair If annual update is not submitted the project is out of compliance. This will generate a notice to the PI, Dept. Chair, Dean and VP, and will initiate The Dreaded Sanctions. Freezing Dept, College, University accounts Restricting Research Activities Closing the Laboratory

REMEMBER All Research involving rDNA and biohazardous materials, sponsored or not, is subject to all the compliance issues just discussed. Compliance is the responsibility of the PI, but the Dept. Chair/Head has an obligation to ensure all PIs are aware of the rules.